Please find attached the Notice of Extraordinary General Meeting scheduled to be held on 28th April, 2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Asston Pharmaceuticals Limited has called an Extraordinary General Meeting (EGM) on 28th April 2026 at 12:30 PM via video conferencing. The meeting will address four key items: (1) Appointment of M/s Panchal SK & Associates as new statutory auditors to fill the vacancy caused by the resignation of M/s Doshi Doshi & Co, who resigned on 28th January 2026; (2) Regularization of Mr. Yogesh Prakash Supekar as Non-Executive Non-Independent Director (appointed since October 2025); (3) Regularization of Mr. Yashvardhan Nitin Tupe as Non-Executive Non-Independent Director (appointed since March 2026); and (4) Regularization of Mr. Sandip Sharma as Non-Executive Independent Director for a 5-year term. The e-voting period runs from 23rd April to 27th April 2026, with 17th April 2026 as the cut-off date for eligible voters.
The EGM addresses routine governance matters including auditor change and director appointments. Shareholders should review the proposals and participate in voting. The resignation of the previous auditor and subsequent appointment of new auditors may indicate management changes or operational adjustments, though this appears to be a standard procedural matter.